Title: Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: analysis of the REDES study.
Citation: Front Immunol
2023;14:1150162.
Country: Spain | Indication: Asthma
http://tago.ca/37122713
Title: Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: analysis of the REDES study.
Citation: Front Immunol
2023;14:1150162.
Country: Spain | Indication: Asthma
Title: Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: analysis of the REDES study.
Citation: Front Immunol
2023;14:1150162.
Country: Spain | Indication: Asthma